15 Related party transactions

(a) Key management personnel compensation

Detailed remuneration disclosures are provided in the remuneration report on pages 55 to 64.

(b) Transactions with key management personnel

The following transactions occurred with key management personnel:

(i) Forfeiture payments expense to key management personal

The group has entered agreements to pay employees for forfeiture of long-term incentives with their former employment. At 30 June 2026 the group has recognized nil as payable for the current year in cash. The expense is cumulative and vests dependent to the employees’ agreements with Radiopharm. At 30 June 2025, the group has recognized $46,367 as payable in cash and at 30 June 2024, the group recognized $490,335 as payable in cash.

(ii) Payments to director related entities

In the fiscal year of 2026, the Acclime Group invoiced Radiopharm for professional services such as financial reporting, capital management, company secretarial, accounting, bookkeeping, and payroll activities, amounting to $171,176 during the time that Mr. Hains, a Director of Acclime Australia, was a of Director of Radiopharm up to November 2025.

(c) Loans to/from related parties

During the financial year ended 30 June 2024, Radiopharm received interest free loans amounting to $2,200,000 from director related entities. The loans were all repaid prior to 30 June 2024. There were no loans in fiscal 2026 (2025: nil).